SigmaStar Technology
301536
Jiangsu Apon Medical Technology
300753
Hunan Friendship & Apollo Commercial
002277
Shanghai Welltech Automation
002058
Innovative Medical Management
002173
CN Stock MarketDetailed Quotes
603360 Dalian Bio-Chem
- 21.44
- -0.34-1.56%
Trading Dec 19 09:30 CST
10.82BMarket Cap36.09P/E (TTM)
21.78High21.42Low7.32KlotVolume21.78Open21.78Pre Close15.89MTurnover0.15%Turnover Ratio32.93P/E (Static)504.45MShares29.8052wk High6.38P/B10.82BFloat Cap5.2152wk Low23.96Limit Up504.45MShs Float29.80Historical High19.60Limit Down1.65%Amplitude1.09Historical Low0.43Dividend TTM21.69Avg Price2.90KlotAsk2.00%Div YieldTTM100Lot Size738.00lotBid
Dalian Bio-Chem Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -8.60%680.54M | -3.35%461.47M | 6.36%219.47M | -16.59%944.19M | -10.70%744.56M | -7.91%477.47M | -9.02%206.35M | 49.28%1.13B | 52.05%833.78M | 47.46%518.46M |
| Refunds of taxes and levies | 57.11%38M | 67.68%28.34M | 49.96%12.63M | -12.62%31.91M | -41.49%24.19M | -43.83%16.9M | -22.79%8.42M | 47.13%36.52M | 78.50%41.34M | 66.80%30.09M |
| Cash received relating to other operating activities | 17.76%20.62M | -12.06%9.28M | -9.47%4.54M | 49.34%22.85M | 99.90%17.51M | 0.64%10.55M | -24.40%5.01M | -15.59%15.3M | 9.87%8.76M | 185.13%10.49M |
| Cash inflows from operating activities | -5.99%739.16M | -1.16%499.08M | 7.67%236.64M | -15.61%998.95M | -11.04%786.25M | -9.68%504.92M | -10.05%219.78M | 47.74%1.18B | 52.53%883.88M | 49.75%559.03M |
| Goods services cash paid | -1.45%247.32M | 90.84%269.83M | 391.42%201.8M | -21.82%302.3M | -6.52%250.97M | -32.39%141.39M | -40.10%41.07M | -2.81%386.68M | -1.55%268.47M | 30.34%209.13M |
| Staff behalf paid | 5.76%85.07M | 0.73%57.06M | 5.36%30.93M | -8.79%105.2M | -8.61%80.43M | -2.31%56.64M | -4.76%29.35M | 13.46%115.34M | 25.34%88.01M | 27.10%57.98M |
| All taxes paid | 65.13%78.19M | 210.78%61.78M | 88.72%20.96M | -15.96%68.32M | -28.51%47.35M | -25.67%19.88M | 237.03%11.1M | 30.32%81.29M | 32.55%66.24M | -24.11%26.74M |
| Cash paid relating to other operating activities | 7.82%92.74M | 4.15%52.92M | 47.10%36.67M | 10.69%133.45M | -6.80%86.02M | -31.71%50.81M | -3.96%24.93M | 23.86%120.56M | 21.63%92.29M | 89.32%74.41M |
| Cash outflows from operating activities | 8.29%503.33M | 64.33%441.59M | 172.76%290.35M | -13.44%609.27M | -9.75%464.78M | -27.03%268.72M | -17.24%106.45M | 6.77%703.87M | 9.87%515.01M | 31.24%368.27M |
| Net cash flows from operating activities | -26.64%235.84M | -75.66%57.5M | -147.40%-53.72M | -18.80%389.69M | -12.85%321.48M | 23.82%236.2M | -2.06%113.33M | 237.90%479.9M | 233.12%368.86M | 105.77%190.76M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | --95.54M | --95.54M | ---- | --181.18M | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash received from returns on investments | --929.42K | --929.42K | ---- | -64.65%332K | ---- | ---- | ---- | -62.34%939.26K | -68.65%110.96K | -68.65%110.96K |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | -47.30%52.7K | -57.40%42.6K | ---- | 16,566.67%100K | 2,834.27%100K | 2,834.27%100K | --100K | -96.17%600 | -69.95%3.41K | -51.31%3.41K |
| Net cash received from disposal of subsidiaries and other business units | --31.1M | --28M | ---- | ---- | ---- | ---- | ---- | --12.25M | ---- | ---- |
| Cash received relating to other investing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --1.3M | --12.22M | --12.22M |
| Cash inflows from investing activities | 127,522.51%127.62M | 124,416.02%124.52M | ---- | 1,153.61%181.61M | -99.19%100K | -99.19%100K | -86.36%100K | -89.83%14.49M | 19.02%12.34M | 19.07%12.34M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -19.03%48.63M | -60.69%20.49M | 43.97%14.65M | -49.84%67.35M | -55.29%60.07M | -56.77%52.13M | -88.37%10.17M | -29.92%134.28M | -20.37%134.34M | 6.28%120.6M |
| Cash paid to acquire investments | --175.54M | --35.54M | ---- | --241.18M | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash paid relating to other investing activities | --50.95M | --50.34M | --270K | ---- | ---- | ---- | ---- | 270.08%4.81M | ---- | ---- |
| Cash outflows from investing activities | 358.03%275.12M | 104.05%106.38M | 46.63%14.92M | 121.81%308.53M | -55.29%60.07M | -56.77%52.13M | -88.37%10.17M | -27.90%139.1M | -22.70%134.34M | 1.73%120.6M |
| Net cash flows from investing activities | -145.97%-147.5M | 134.86%18.14M | -48.08%-14.92M | -1.85%-126.92M | 50.85%-59.97M | 51.94%-52.03M | 88.39%-10.07M | -147.24%-124.61M | 25.34%-122M | -0.07%-108.26M |
| Financing cash flow | ||||||||||
| Cash from borrowing | 105.00%205M | 310.00%205M | 200.00%150M | 51.48%149.97M | -0.12%100M | 0.00%50M | 0.58%50M | -75.16%99M | -74.87%100.12M | -87.45%50M |
| Cash received relating to other financing activities | 37.32%68.92M | --68.92M | --50M | -53.77%51.41M | -40.54%50.19M | ---- | ---- | 21.17%111.21M | -65.09%84.4M | -59.32%77.41M |
| Cash inflows from financing activities | 82.38%273.92M | 447.84%273.92M | 300.00%200M | -4.20%201.38M | -18.61%150.19M | -60.76%50M | -2.78%50M | -57.12%210.21M | -71.18%184.53M | -78.36%127.41M |
| Borrowing repayment | 102.02%200M | 200.00%150M | 100.00%100M | -54.73%129M | -70.71%99M | -82.46%50M | -56.52%50M | 156.09%284.99M | 1,589.94%337.99M | 1,324.94%284.99M |
| Dividend interest payment | 6.78%220.8M | 7.19%220.11M | -18.06%1.97M | 3,084.11%206.86M | 3,680.30%206.77M | 4,425.99%205.35M | -5.99%2.41M | -95.91%6.5M | -96.41%5.47M | -97.02%4.54M |
| Cash payments relating to other financing activities | 2.80%3.62M | 495.22%3.62M | --320.36K | -40.08%53.68M | -90.57%3.52M | --607.92K | ---- | -67.85%89.59M | -91.17%37.31M | ---- |
| Cash outflows from financing activities | 37.22%424.42M | 46.01%373.73M | 95.19%102.29M | 2.22%389.54M | -18.77%309.29M | -11.59%255.96M | -55.31%52.41M | -30.58%381.07M | -36.01%380.77M | -51.32%289.52M |
| Net cash flows from financing activities | 5.41%-150.5M | 51.54%-99.81M | 4,161.46%97.71M | -10.13%-188.16M | 18.92%-159.1M | -27.05%-205.96M | 96.35%-2.41M | -191.29%-170.86M | -534.04%-196.24M | -2,618.79%-162.11M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | 392.56%6.95M | 5,068.54%5.42M | 139.68%783.63K | 1,786.33%3.4M | -56.89%1.41M | -107.72%-109.14K | -5,166.85%-1.97M | 61.67%-201.87K | 534.72%3.27M | 49,465.14%1.41M |
| Net increase in cash and cash equivalents | -153.18%-55.21M | 14.37%-18.75M | -69.80%29.86M | -57.66%78.01M | 92.62%103.82M | 71.99%-21.9M | 368.59%98.88M | 467.87%184.23M | 875.01%53.9M | -264.75%-78.19M |
| Add:Begin period cash and cash equivalents | 19.73%473.39M | 19.73%473.39M | 19.73%473.39M | 87.25%395.38M | 86.26%395.38M | 87.25%395.38M | 87.25%395.38M | 18.15%211.15M | 18.78%212.27M | 18.15%211.15M |
| End period cash equivalent | -16.23%418.18M | 21.73%454.64M | 1.82%503.25M | 19.73%473.39M | 87.55%499.2M | 180.91%373.48M | 183.51%494.26M | 87.25%395.38M | 54.98%266.17M | -15.46%132.96M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Grant Thornton Certified Public Accountants (Special General Partnership) | -- | -- | -- | Dahua Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
